Latest news
Attovia Therapeutics (ATTO) major holder converts 18.2M preferred into common - Stock TitanStock Titan · Mon, 10 Aug 2026 20:31:25 GMTAttovia Therapeutics (ATTO): venBio fund converts preferred in IPO, buys $17 shares - Stock TitanStock Titan · Mon, 10 Aug 2026 20:12:43 GMTAttovia Therapeutics (ATTO) CFO discloses two long-dated stock option grants - Stock TitanStock Titan · Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) insider reports initial stock and option holdings - Stock TitanStock Titan · Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) director discloses 72,792-share option grant and vesting terms - Stock TitanStock Titan · Mon, 10 Aug 2026 13:26:21 GMTAttovia Therapeutics (ATTO) director Angie You receives 27,000 stock options at $17 - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:44 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Medical Officer - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:23 GMTAttovia Therapeutics (ATTO) awards 140,000 stock options to Chief Business Officer - Stock TitanStock Titan · Sat, 08 Aug 2026 18:11:23 GMT